Compile Data Set for Download or QSAR
Found 132 of kd for UniProtKB: P40337
Targetvon Hippel-Lindau disease tumor suppressor(Homo sapiens (Human))
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY

US Patent
LigandPNGBDBM454969(US10730870, Example 138 | US10730870, Example 145 ...)copy SMILEScopy InChI
Affinity DataKd:  10nMAssay Description:The surface plasmon resonance (SPR) experiments were conducted on a Biacore3000 (GE Healthcare). His-tagged VHL protein was immobilized on a carboxym...More data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2WD43MNUS Patent
Targetvon Hippel-Lindau disease tumor suppressor(Homo sapiens (Human))
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY

US Patent
LigandPNGBDBM50404375(CHEMBL5274307)copy SMILEScopy InChI
Affinity DataKd:  11nMAssay Description:In vitro antagonism of the 5-HT-3 receptor determined by inhibition of 5-HT-induced depolarization of the isolated rat vagus nerve.More data for this Ligand-Target Pair
In DepthDetails
Targetvon Hippel-Lindau disease tumor suppressor(Homo sapiens (Human))
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY

US Patent
LigandPNGBDBM50459880(CHEMBL4226570)copy SMILEScopy InChI
Affinity DataKd:  34nMAssay Description:Binding affinity to N-terminal His6-tagged VHL (54 to 213 residues) (unknown origin) expressed in Escherichia coli assessed as displacement of HIF-1a...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q29P35H7PubMed
Targetvon Hippel-Lindau disease tumor suppressor(Homo sapiens (Human))
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY

US Patent
LigandPNGBDBM50581595(CHEMBL4215078)copy SMILES
Affinity DataKd:  34nMAssay Description:Binding affinity to N-terminal His6-tagged VHL (54 to 213 residues) (unknown origin) expressed in Escherichia coli assessed as displacement of HIF-1a...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q29P35H7PubMed
Targetvon Hippel-Lindau disease tumor suppressor(Homo sapiens (Human))
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY

US Patent
LigandPNGBDBM50586757(CHEMBL5089280)copy SMILES
Affinity DataKd:  45nMAssay Description:Binding affinity to VHL (unknown origin) assessed as displacement of HIF-1alpha by binary binding competitive fluorescence polarization assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q23N27B7PubMed
Targetvon Hippel-Lindau disease tumor suppressor(Homo sapiens (Human))
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY

US Patent
LigandPNGBDBM50611349(CHEMBL5283149)copy SMILES
Affinity DataKd:  47nMMore data for this Ligand-Target Pair
Ligand Info
In DepthDetails
Targetvon Hippel-Lindau disease tumor suppressor(Homo sapiens (Human))
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY

US Patent
LigandPNGBDBM50459944(CHEMBL4225537)copy SMILEScopy InChI
Affinity DataKd:  58nMAssay Description:Displacement of FAM-labeled HIF-1alpha peptide from VCB (unknown origin) by fluorescence polarization assayMore data for this Ligand-Target Pair
Targetvon Hippel-Lindau disease tumor suppressor(Homo sapiens (Human))
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY

US Patent
LigandPNGBDBM50581599(CHEMBL5087181)copy SMILES
Affinity DataKd:  63nMAssay Description:Binding affinity to N-terminal His6-tagged VHL (54 to 213 residues) (unknown origin) expressed in Escherichia coli assessed as displacement of HIF-1a...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q29P35H7PubMed
Targetvon Hippel-Lindau disease tumor suppressor(Homo sapiens (Human))
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY

US Patent
LigandPNGBDBM50581597(CHEMBL5074720)copy SMILES
Affinity DataKd:  66nMAssay Description:Binding affinity to N-terminal His6-tagged VHL (54 to 213 residues) (unknown origin) expressed in Escherichia coli assessed as displacement of HIF-1a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q29P35H7PubMed
Targetvon Hippel-Lindau disease tumor suppressor(Homo sapiens (Human))
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY

US Patent
LigandPNGBDBM50459880(CHEMBL4226570)copy SMILEScopy InChI
Affinity DataKd:  66nMMore data for this Ligand-Target Pair
In DepthDetails
Targetvon Hippel-Lindau disease tumor suppressor(Homo sapiens (Human))
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY

US Patent
LigandPNGBDBM50459944(CHEMBL4225537)copy SMILEScopy InChI
Affinity DataKd:  90nMAssay Description:Binding affinity to VHL (unknown origin)More data for this Ligand-Target Pair
Targetvon Hippel-Lindau disease tumor suppressor(Homo sapiens (Human))
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY

US Patent
LigandPNGBDBM50581596(CHEMBL5075400)copy SMILES
Affinity DataKd:  98nMAssay Description:Binding affinity to N-terminal His6-tagged VHL (54 to 213 residues) (unknown origin) expressed in Escherichia coli assessed as displacement of HIF-1a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q29P35H7PubMed
Targetvon Hippel-Lindau disease tumor suppressor(Homo sapiens (Human))
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY

US Patent
LigandPNGBDBM50586758(CHEMBL5081978)copy SMILES
Affinity DataKd:  102nMAssay Description:Binding affinity to VHL (unknown origin) assessed as displacement of HIF-1alpha by binary binding competitive fluorescence polarization assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q23N27B7PubMed
Targetvon Hippel-Lindau disease tumor suppressor(Homo sapiens (Human))
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY

US Patent
LigandPNGBDBM50099062(CHEMBL3344081 | US10730870, Example 3 | US11512083...)copy SMILEScopy InChI
Affinity DataKd:  113nMAssay Description:Binding affinity to N-terminal His6-tagged VHL (54 to 213 residues) (unknown origin) expressed in Escherichia coli assessed as displacement of HIF-1a...More data for this Ligand-Target Pair
Targetvon Hippel-Lindau disease tumor suppressor(Homo sapiens (Human))
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY

US Patent
LigandPNGBDBM50581587(CHEMBL5087145)copy SMILES
Affinity DataKd:  119nMAssay Description:Binding affinity to N-terminal His6-tagged VHL (54 to 213 residues) (unknown origin) expressed in Escherichia coli assessed as displacement of HIF-1a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q29P35H7PubMed
Targetvon Hippel-Lindau disease tumor suppressor(Homo sapiens (Human))
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY

US Patent
LigandPNGBDBM50099062(CHEMBL3344081 | US10730870, Example 3 | US11512083...)copy SMILEScopy InChI
Affinity DataKd:  120nMAssay Description:The surface plasmon resonance (SPR) experiments were conducted on a Biacore3000 (GE Healthcare). His-tagged VHL protein was immobilized on a carboxym...More data for this Ligand-Target Pair
Targetvon Hippel-Lindau disease tumor suppressor(Homo sapiens (Human))
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY

US Patent
LigandPNGBDBM50586756(CHEMBL5089544)copy SMILES
Affinity DataKd:  125nMAssay Description:Binding affinity to VHL (unknown origin) assessed as displacement of HIF-1alpha by binary binding competitive fluorescence polarization assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q23N27B7PubMed
Targetvon Hippel-Lindau disease tumor suppressor(Homo sapiens (Human))
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY

US Patent
LigandPNGBDBM50581588(CHEMBL5082521)copy SMILES
Affinity DataKd:  136nMAssay Description:Binding affinity to N-terminal His6-tagged VHL (54 to 213 residues) (unknown origin) expressed in Escherichia coli assessed as displacement of HIF-1a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q29P35H7PubMed
Targetvon Hippel-Lindau disease tumor suppressor(Homo sapiens (Human))
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY

US Patent
LigandPNGBDBM50581589(CHEMBL4793272)copy SMILES
Affinity DataKd:  138nMAssay Description:Binding affinity to N-terminal His6-tagged VHL (54 to 213 residues) (unknown origin) expressed in Escherichia coli assessed as displacement of HIF-1a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q29P35H7PubMed
Targetvon Hippel-Lindau disease tumor suppressor(Homo sapiens (Human))
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY

US Patent
LigandPNGBDBM50581601(CHEMBL5079045)copy SMILES
Affinity DataKd:  143nMAssay Description:Binding affinity to N-terminal His6-tagged VHL (54 to 213 residues) (unknown origin) expressed in Escherichia coli assessed as displacement of HIF-1a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q29P35H7PubMed
Targetvon Hippel-Lindau disease tumor suppressor(Homo sapiens (Human))
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY

US Patent
LigandPNGBDBM50581590(CHEMBL5081396)copy SMILES
Affinity DataKd:  144nMAssay Description:Binding affinity to N-terminal His6-tagged VHL (54 to 213 residues) (unknown origin) expressed in Escherichia coli assessed as displacement of HIF-1a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q29P35H7PubMed
Targetvon Hippel-Lindau disease tumor suppressor(Homo sapiens (Human))
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY

US Patent
LigandPNGBDBM50581592(CHEMBL5094871)copy SMILES
Affinity DataKd:  170nMAssay Description:Binding affinity to N-terminal His6-tagged VHL (54 to 213 residues) (unknown origin) expressed in Escherichia coli assessed as displacement of HIF-1a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q29P35H7PubMed
Targetvon Hippel-Lindau disease tumor suppressor(Homo sapiens (Human))
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY

US Patent
LigandPNGBDBM50581591(CHEMBL5087530)copy SMILES
Affinity DataKd:  170nMAssay Description:Binding affinity to N-terminal His6-tagged VHL (54 to 213 residues) (unknown origin) expressed in Escherichia coli assessed as displacement of HIF-1a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q29P35H7PubMed
Targetvon Hippel-Lindau disease tumor suppressor(Homo sapiens (Human))
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY

US Patent
LigandPNGBDBM50099062(CHEMBL3344081 | US10730870, Example 3 | US11512083...)copy SMILEScopy InChI
Affinity DataKd:  185nMMore data for this Ligand-Target Pair
Targetvon Hippel-Lindau disease tumor suppressor(Homo sapiens (Human))
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY

US Patent
LigandPNGBDBM50099062(CHEMBL3344081 | US10730870, Example 3 | US11512083...)copy SMILEScopy InChI
Affinity DataKd:  185nMAssay Description:Binding affinity to N-terminal His6-tagged pVHL (54 to 213 amino acids) (unknown origin) expressed in Escherichia coli BL21 (DE3) by isothermal titra...More data for this Ligand-Target Pair
Targetvon Hippel-Lindau disease tumor suppressor(Homo sapiens (Human))
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY

US Patent
LigandPNGBDBM50581593(CHEMBL5086047)copy SMILES
Affinity DataKd:  200nMAssay Description:Binding affinity to N-terminal His6-tagged VHL (54 to 213 residues) (unknown origin) expressed in Escherichia coli assessed as displacement of HIF-1a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q29P35H7PubMed
Targetvon Hippel-Lindau disease tumor suppressor(Homo sapiens (Human))
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY

US Patent
LigandPNGBDBM50581594(CHEMBL5086897)copy SMILES
Affinity DataKd:  200nMAssay Description:Binding affinity to N-terminal His6-tagged VHL (54 to 213 residues) (unknown origin) expressed in Escherichia coli assessed as displacement of HIF-1a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q29P35H7PubMed
Targetvon Hippel-Lindau disease tumor suppressor(Homo sapiens (Human))
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY

US Patent
LigandPNGBDBM50581600(CHEMBL5086339)copy SMILES
Affinity DataKd:  236nMAssay Description:Binding affinity to N-terminal His6-tagged VHL (54 to 213 residues) (unknown origin) expressed in Escherichia coli assessed as displacement of HIF-1a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q29P35H7PubMed
Targetvon Hippel-Lindau disease tumor suppressor(Homo sapiens (Human))
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY

US Patent
LigandPNGBDBM454980(US10730870, Example 207)copy SMILEScopy InChI
Affinity DataKd:  240nMAssay Description:The surface plasmon resonance (SPR) experiments were conducted on a Biacore3000 (GE Healthcare). His-tagged VHL protein was immobilized on a carboxym...More data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2WD43MNUS Patent
Targetvon Hippel-Lindau disease tumor suppressor(Homo sapiens (Human))
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY

US Patent
LigandPNGBDBM50581598(CHEMBL5081695)copy SMILES
Affinity DataKd:  246nMAssay Description:Binding affinity to N-terminal His6-tagged VHL (54 to 213 residues) (unknown origin) expressed in Escherichia coli assessed as displacement of HIF-1a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q29P35H7PubMed
Targetvon Hippel-Lindau disease tumor suppressor(Homo sapiens (Human))
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY

US Patent
LigandPNGBDBM50099055(CHEMBL3344088)copy SMILEScopy InChI
Affinity DataKd:  291nMAssay Description:Binding affinity to N-terminal His6-tagged pVHL (54 to 213 amino acids) (unknown origin) expressed in Escherichia coli BL21 (DE3) by isothermal titra...More data for this Ligand-Target Pair
Targetvon Hippel-Lindau disease tumor suppressor(Homo sapiens (Human))
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY

US Patent
LigandPNGBDBM454979(US10730870, Example 205)copy SMILEScopy InChI
Affinity DataKd:  330nMAssay Description:The surface plasmon resonance (SPR) experiments were conducted on a Biacore3000 (GE Healthcare). His-tagged VHL protein was immobilized on a carboxym...More data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2WD43MNUS Patent
Targetvon Hippel-Lindau disease tumor suppressor(Homo sapiens (Human))
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY

US Patent
LigandPNGBDBM50099058(CHEMBL3344084)copy SMILEScopy InChI
Affinity DataKd:  384nMAssay Description:Binding affinity to N-terminal His6-tagged pVHL (54 to 213 amino acids) (unknown origin) expressed in Escherichia coli BL21 (DE3) by isothermal titra...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2HD7XDMPubMed
Targetvon Hippel-Lindau disease tumor suppressor(Homo sapiens (Human))
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY

US Patent
LigandPNGBDBM454858(US10730870, Example 21 | US11512083, Example 21)copy SMILEScopy InChI
Affinity DataKd:  450nMAssay Description:Displacement of FAM-labeled HIF-1alpha peptide from VCB (unknown origin) by fluorescence polarization assayMore data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2Q243Z4PubMed
Targetvon Hippel-Lindau disease tumor suppressor(Homo sapiens (Human))
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY

US Patent
LigandPNGBDBM50246759(CHEMBL4098772)copy SMILEScopy InChI
Affinity DataKd:  500nMAssay Description:Binding affinity to VHL (unknown origin) assessed as reduction of HIF1alpha derived peptide binding to VHL complex by competitive binding fluorescenc...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q22R3V26PubMed
Targetvon Hippel-Lindau disease tumor suppressor(Homo sapiens (Human))
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY

US Patent
LigandPNGBDBM50099056(CHEMBL3344087)copy SMILEScopy InChI
Affinity DataKd:  588nMAssay Description:Binding affinity to N-terminal His6-tagged pVHL (54 to 213 amino acids) (unknown origin) expressed in Escherichia coli BL21 (DE3) by isothermal titra...More data for this Ligand-Target Pair
Targetvon Hippel-Lindau disease tumor suppressor(Homo sapiens (Human))
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY

US Patent
LigandPNGBDBM50099060(CHEMBL3344083)copy SMILEScopy InChI
Affinity DataKd:  714nMAssay Description:Binding affinity to N-terminal His6-tagged pVHL (54 to 213 amino acids) (unknown origin) expressed in Escherichia coli BL21 (DE3) by isothermal titra...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2HD7XDMPubMed
Targetvon Hippel-Lindau disease tumor suppressor(Homo sapiens (Human))
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY

US Patent
LigandPNGBDBM50561318(CHEMBL4782620)copy SMILES
Affinity DataKd:  800nMAssay Description:Displacement of FAM-labeled HIF-1alpha peptide from VCB (unknown origin) by fluorescence polarization assayMore data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2Q243Z4PubMed
Targetvon Hippel-Lindau disease tumor suppressor(Homo sapiens (Human))
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY

US Patent
LigandPNGBDBM50099061(CHEMBL3344082)copy SMILEScopy InChI
Affinity DataKd:  826nMAssay Description:Binding affinity to N-terminal His6-tagged pVHL (54 to 213 amino acids) (unknown origin) expressed in Escherichia coli BL21 (DE3) by isothermal titra...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2HD7XDMPubMed
Targetvon Hippel-Lindau disease tumor suppressor(Homo sapiens (Human))
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY

US Patent
LigandPNGBDBM50099057(CHEMBL3344086)copy SMILEScopy InChI
Affinity DataKd:  943nMAssay Description:Binding affinity to N-terminal His6-tagged pVHL (54 to 213 amino acids) (unknown origin) expressed in Escherichia coli BL21 (DE3) by isothermal titra...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2HD7XDMPubMed
Targetvon Hippel-Lindau disease tumor suppressor(Homo sapiens (Human))
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY

US Patent
LigandPNGBDBM622037(US20230312542, Example 159)copy SMILES
Affinity DataKd: <1.00E+3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
Targetvon Hippel-Lindau disease tumor suppressor(Homo sapiens (Human))
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY

US Patent
LigandPNGBDBM622036(US20230312542, Example 158)copy SMILES
Affinity DataKd: <1.00E+3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
Targetvon Hippel-Lindau disease tumor suppressor(Homo sapiens (Human))
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY

US Patent
LigandPNGBDBM622034(US20230312542, Example 154)copy SMILES
Affinity DataKd: <1.00E+3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
Targetvon Hippel-Lindau disease tumor suppressor(Homo sapiens (Human))
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY

US Patent
LigandPNGBDBM622033(US20230312542, Example 153)copy SMILES
Affinity DataKd: <1.00E+3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
Targetvon Hippel-Lindau disease tumor suppressor(Homo sapiens (Human))
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY

US Patent
LigandPNGBDBM622023(US20230312542, Example 111)copy SMILES
Affinity DataKd: <1.00E+3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
Targetvon Hippel-Lindau disease tumor suppressor(Homo sapiens (Human))
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY

US Patent
LigandPNGBDBM622022(US20230312542, Example 108)copy SMILES
Affinity DataKd: <1.00E+3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
Targetvon Hippel-Lindau disease tumor suppressor(Homo sapiens (Human))
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY

US Patent
LigandPNGBDBM622021(US20230312542, Example 107)copy SMILES
Affinity DataKd: <1.00E+3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
Targetvon Hippel-Lindau disease tumor suppressor(Homo sapiens (Human))
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY

US Patent
LigandPNGBDBM621993(US20230312542, Example 44)copy SMILES
Affinity DataKd: <1.00E+3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
Targetvon Hippel-Lindau disease tumor suppressor(Homo sapiens (Human))
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY

US Patent
LigandPNGBDBM621998(US20230312542, Example 54)copy SMILES
Affinity DataKd: <1.00E+3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
Targetvon Hippel-Lindau disease tumor suppressor(Homo sapiens (Human))
ARVINAS OPERATIONS, INC.; YALE UNIVERSITY

US Patent
LigandPNGBDBM50099059(CHEMBL3344085)copy SMILEScopy InChI
Affinity DataKd:  1.10E+3nMAssay Description:Binding affinity to N-terminal His6-tagged pVHL (54 to 213 amino acids) (unknown origin) expressed in Escherichia coli BL21 (DE3) by isothermal titra...More data for this Ligand-Target Pair
Displayed 1 to 50 (of 132 total ) | Next | Last >>
Jump to: